Prof. Akiko Iwasaki Profile picture
Mar 3, 2024 16 tweets 6 min read Read on X
Delighted to share our latest work on #longCOVID - sex differences in symptoms and immune signatures. Led by @SilvaJ_C @taka_takehiro @wood_jamie_1 et al. with @LeyingGuan & @PutrinoLab. We find a striking inverse correlation btw testosterone levels and symptom burden👇🏼 (1/)

medrxiv.org/content/10.110…
This work leverages data from our recent Mount Sinai-Yale long COVID "MY-LC" study with the @PutrinoLab. This time, we asked the question, "Are there differences in symptoms and immune signatures of ♀️ vs. ♂️ with LC"? (2/)

nature.com/articles/s4158…
Image
While some symptoms were equally frequent in females and males, many were more frequent in females (e.g., swelling, headaches, muscle pain, cramps) than males. The top distinguishing symptoms of LC status by sex were hair loss in females and sexual dysfunction in males. (3/) Image
What organ-specific symptoms correlate with one another in females vs. males? In females (left), temperature-related symptoms and musculoskeletal symptoms were strongly associated with other symptoms. In males (right), ear nose and throat (ENT) symptoms were most associated with other symptoms. (4/)Image
What about immune signatures? Females with LC had increases in exhausted and cytokine-secreting T cells and antibodies against lytic antigens from herpesviruses, suggestive of recent reactivation. (5/) Image
In contrast, males with LC had elevated NK cells, reduced monocytes and plasmacytoid dendritic cells. They also had increases in TGF-beta, APRIL and IL-8, features not significantly different in females with LC. (6/) Image
Females with LC had significantly lower testosterone levels. Using logistic regression, @SilvaJ_C found testosterone to be the top negative hormone predictor of LC status in females based on per unit odds ratio. Thus, in females, the lower the testosterone, the more likely to have LC. (7/)Image
In males, those with LC had lower levels of estradiol, and estradiol was found to be the top negative predictor hormone of LC status. (8/) Image
Next, @silvaJ_C took a different machine-learning approach. This time he divided the MY-LC cohort into training vs. testing sets. He took cellular profiles and plasma factors but excluded hormones within females and males separately and calculated sex-specific immune scores. (9/) Image
This strategy successfully predicted LC status in females (86% accuracy) and males (87% accuracy). Meaning that cellular and soluble immune features alone can distinguish those with LC in both sexes pretty accurately. (10/) Image
Using this modeling strategy, we found that female LC immune signatures were associated with higher symptom burden, organ involvement and dysautonomia in males with LC. Conversely, male LC immune signatures correlated with lower symptom burden, dysautonomia and neurocognitive symptoms in females with LC! Overall, male LC immune signatures meant less symptoms in LC. (11/)Image
So what is driving the male LC immune signatures? Testosterone! Regardless of sex, those with higher testosterone levels had higher male LC immune signatures. Those with lower testosterone had higher female LC immune signatures. (12/) Image
Finally, testosterone levels could significantly predict not just LC status but also symptom burden and organ system involvement in individuals with LC irrespective of sex. (13/) Image
To summarize, we find significant differences in symptoms and immune signatures in females vs. males with long COVID. (14/) Image
There is a fascinating backstory to this study I wish to share (with permission). In August of 2022, @tarazupancic DM me about a profound improvement in the long COVID symptoms of her child after receiving testosterone for gender-affirming care. I discussed this at our weekly long COVID lab science meeting. This is how it all started. So grateful to Tara for sharing this key insight with us 🙏🏼🙏🏼 (15/)
As always, this was a huge undertaking by many dedicated scientists and clinicians, and the amazing contributions of patients who donated their time, effort and blood samples. Incredible teamwork with the Mount Sinai team @PutrinoLab. Kudos to @SilvaJ_C, @taka_takehiro, @wood_jamie_1, @peowenlu, @S_Tabachnikova, @JeffGehlhausen, @KerrieGreene_ , @bornali_27, Valter Silva Monteiro, @carolilucas, @rahuldhodapkar, @marioph13, Kathy Kamath, @tianyangmao, Dayna Mccarthy, @RMedzhitov, @david_van_dijk, @hmkyale and @LeyingGuan!!Image

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Prof. Akiko Iwasaki

Prof. Akiko Iwasaki Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @VirusesImmunity

Feb 20
Our preprint on post-vaccination syndrome is out. We studied immune signatures and examined spike protein in the blood of people who have developed chronic illnesses after COVID-19 vaccination. (1/) medrxiv.org/content/10.110…
Vaccines have saved countless lives and inspired me to become an immunologist. While generally safe, some people experience adverse effects, including Post-Vaccination Syndrome (PVS). Studying PVS is crucial for improving patient care and enhancing vaccine safety & acceptance. (2/) pubmed.ncbi.nlm.nih.gov/37986769/
To explain the study and results, @MalloryLocklear wrote this excellent summary. (3/)
news.yale.edu/2025/02/19/imm…
Read 6 tweets
Nov 8, 2024
Happy to share our latest work by @YYexin et al. on antibody-mediated control of endogenous retroviruses in mice. In the process, we found “natural antibodies” with broad reactivity against enveloped viruses. Here is how “panviral” antibodies work 🧵(1/)

science.org/doi/10.1126/sc…
Endogenous retroviruses (ERV) are remnants of genetic invaders that have integrated into our ancestors' genomes over millions of years. ERVs occupy ~8% of the human genome and are under constant host immune surveillance. (2/)
nature.com/articles/nrg31…
nature.com/articles/nrmic…
This work started over 7 years ago when @YYexin and @rebecca_treger began to examine why ERVs reactivate in certain mouse strains. Through many genetic crosses, we figured out that secreted IgM recruits complement to suppress infectious ERV from emerging. (3/) Image
Read 16 tweets
Oct 13, 2024
This time, we developed a nasal booster vaccine for influenza viruses. In this preprint, @MiyuMoriyama et al. show that nasal boosters with unadjuvanted hemagglutinin protein induce sterilizing immunity in mice against flu. (1/)
biorxiv.org/content/10.110…
This work builds on the Prime and Spike vaccine strategy by @tianyangmao @BenIsraelow et al. against COVID where mRNA vaccine followed by nasal booster with recombinant spike protein established local immunity, ⬇️ infection & transmission in rodents. (2/)
science.org/doi/10.1126/sc…
For Prime and HA against flu, @MiyuMoriyama tested several different mRNA IM prime and nasal HA booster doses, followed by a homologous influenza virus challenge. Like Prime and Spike, no adjuvant is needed for the nasal booster due to preexisting immunity from Prime. (3/) Image
Read 11 tweets
Oct 11, 2024
Much-needed data on the genetics of #longCOVID in a new preprint by @23andMeResearch - GWAS of #LongCOVID identified 3 loci pointing to immune and thrombo-inflammatory mechanisms 🔥 @ninaadsc
1) HLA-DQA1–HLA-DQB
2) ABO
3) BPTF–KPAN2–C17orf58
(1/)
medrxiv.org/content/10.110…Image
Among research participants who reported acute SARS-CoV2 infection, 64,384 participants reported to have experienced Long COVID and 178,537 participants did not. Their analytical cohort consisted of 54,390 cases and 124,777 controls 👇🏼 (2/) Image
The top locus was in the HLA-DQA1–HLA-DQB intergenic region. Further analysis showed that HLA alleles HLA-DRB1*11:04, HLA-C*07:01, HLA-B*08:01, and HLA-DQA1*03:01 were significantly associated with #LongCOVID. In other words, crucial genes for T cell target detection! (3/)
Read 8 tweets
Oct 4, 2024
Keynote talk by @MichaelPelusoMD. “#LongCovid is not a mystery anymore. Working with patients, I have optimism that we can figure this out.” #YaleCIISymposium Image
An excellent framework in thinking about the pathogenesis of #LongCovid
@MichaelPelusoMD Image
Where we need to go @MichaelPelusoMD Image
Read 4 tweets
Oct 2, 2024
Sharing this scoping review on "Post-Acute sequelae of COVID-19 in pediatric patients within the United States" by @ChrisMillerDO - an amazing @YalePediatrics infectious diseases fellow focused on research and treatment of #longcovidkids (1/)

sciencedirect.com/science/articl…
Key findings:
- Most pediatric LC patients were adolescents.
- ♀>♂️
- 80% of pediatric LC patients started with a mild initial infection.
- Asthma, atopy, allergic rhinitis (type 2 immune diseases), and obesity were frequently reported pre-existing conditions. (2/)
The most frequently reported symptoms in #longcovidkids are listed here (3/) Image
Read 4 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us!

:(